Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 256,783,280
  • Shares Outstanding, K 1,768,480
  • Annual Sales, $ 56,197 M
  • Annual Income, $ 11,542 M
  • 60-Month Beta 0.61
  • Price/Sales 4.46
  • Price/Cash Flow 8.22
  • Price/Book 16.02
Trade ABBV with:

Options Overview Details

View History
  • Implied Volatility 23.98% ( -2.32%)
  • Historical Volatility 17.67%
  • IV Percentile 31%
  • IV Rank 27.63%
  • IV High 35.40% on 09/30/22
  • IV Low 19.62% on 02/09/22
  • Put/Call Vol Ratio 0.51
  • Today's Volume 22,803
  • Volume Avg (30-Day) 39,471
  • Put/Call OI Ratio 0.86
  • Today's Open Interest 365,356
  • Open Int (30-Day) 396,220

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 3.54
  • Number of Estimates 6
  • High Estimate 3.57
  • Low Estimate 3.51
  • Prior Year 3.31
  • Growth Rate Est. (year over year) +6.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
143.44 +1.10%
on 02/02/23
166.28 -12.79%
on 01/09/23
-21.53 (-12.93%)
since 01/06/23
3-Month
143.44 +1.10%
on 02/02/23
168.11 -13.74%
on 01/06/23
-0.26 (-0.18%)
since 11/04/22
52-Week
134.09 +8.15%
on 09/30/22
175.91 -17.56%
on 04/08/22
+4.37 (+3.11%)
since 02/04/22

Most Recent Stories

More News
AbbVie (ABBV) to Report Q4 Earnings: What's in the Cards?

AbbVie's (ABBV) Q4 performance will likely reflect strong drug demand from its immunology and neuroscience franchises. Investors will also enquire about ABBV's plans to counter Humira LOE.

RHHBY : 38.3500 (+0.63%)
JNJ : 163.36 (-0.76%)
BAYRY : 15.6600 (+2.22%)
ABBV : 145.02 (-0.12%)
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income

The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income...

ABBV : 145.02 (-0.12%)
ARLP : 21.61 (-3.14%)
CFG : 43.78 (-1.49%)
Option Volatility And Earnings Report For Feb 6 - 10

Earnings season rolls on for another week with big names such as Enphase Energy, PayPal, On Semiconductor, Uber Technologies, Disney, CVS Corp, AbbieVie, Pepsico, Cloudflare, Affirm Holdings, Robinhood...

ENPH : 222.99 (+0.03%)
PYPL : 82.33 (-3.73%)
ON : 80.40 (-0.61%)
UBER : 33.90 (+2.45%)
DIS : 109.87 (-0.76%)
CVS : 85.25 (-0.61%)
ABBV : 145.02 (-0.12%)
PEP : 171.82 (+1.60%)
NET : 56.65 (-4.68%)
AFRM : 17.01 (-6.28%)
HOOD : 10.60 (-1.30%)
YUM : 129.06 (+1.61%)
Stocks Set To Open Lower As Strong U.S. Jobs Report Sparks Rate Hike Worries

March S&P 500 futures (ESH23) are trending down -0.94% this morning after three major U.S. benchmark indices closed in the red on Friday as a blowout jobs data sparked fears that the Federal Reserve would...

ESH23 : 4,125.75 (+0.05%)
AMZN : 102.18 (-1.17%)
GOOGL : 102.90 (-1.79%)
DIS : 109.87 (-0.76%)
NYT : 36.36 (-0.82%)
UBER : 33.90 (+2.45%)
CVS : 85.25 (-0.61%)
PYPL : 82.33 (-3.73%)
ABBV : 145.02 (-0.12%)
PEP : 171.82 (+1.60%)
K : 69.01 (+2.07%)
NDA.D.DX : 96.400 (-4.65%)
More Earnings On Tap, Powell Speaks And Other Key Themes To Watch This Week

The S&P 500 ($SPX) (SPY) finished January up over 6%, which was a nice change of pace from the total return of 2022. Earnings continued to be mixed throughout last week. The Fed bumped rates in line with...

$SPX : 4,111.08 (-0.61%)
SPY : 409.83 (-0.61%)
$DOWI : 33,891.02 (-0.10%)
DIA : 338.48 (-0.15%)
$IUXX : 12,464.51 (-0.87%)
QQQ : 303.59 (-0.85%)
UBER : 33.90 (+2.45%)
CVS : 85.25 (-0.61%)
DIS : 109.87 (-0.76%)
CME : 174.76 (-1.01%)
PYPL : 82.33 (-3.73%)
EXPE : 119.07 (+0.31%)
2 Stocks Down More Than 6% to Buy Right Now

These companies outperformed the market last year.

JNJ : 163.36 (-0.76%)
ABBV : 145.02 (-0.12%)
3 Unstoppable Dividend Stocks to Buy in February

All three belong to the elite group of stocks known as Dividend Kings.

ABT : 110.75 (-0.93%)
ABBV : 145.02 (-0.12%)
JNJ : 163.36 (-0.76%)
AbbVie Q4 Preview: What's in Store?

AbbVie has put in a mixed earnings performance, exceeding bottom line estimates in five consecutive quarters but falling short of sales expectations in each instance.

AAPL : 151.73 (-1.79%)
MSFT : 256.77 (-0.61%)
MRK : 104.03 (+1.06%)
LLY : 337.66 (-0.42%)
ABBV : 145.02 (-0.12%)
GOOGL : 102.90 (-1.79%)
The Safest Stock to Buy on Wall Street Right Now

With the recent market rally hinged on hopes of an end to the Fed’s hawkishness in the foreseeable future, strong fundamentals of Pfizer (PFE) for excellent value could help investors secure decent risk-adjusted...

ABBV : 145.02 (-0.12%)
BMY : 74.53 (+0.11%)
JNJ : 163.36 (-0.76%)
PFE : 43.76 (-0.68%)
The 5 Best Stocks to Invest $1,000 in Right Now

Improving investors’ sentiments amid the cooling inflation and moderating interest rate increases helped the stock market to surge in recent weeks. Moreover, the IMF raised its world economy growth forecast....

ABBV : 145.02 (-0.12%)
MCFT : 30.71 (-0.58%)
MUSA : 259.75 (+2.36%)
PNRG : 91.00 (-0.33%)
VRTX : 304.87 (+1.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

AbbVie has become one of the top-most pharma companies after it acquired Allergan. The deal has transformed AbbVie's portfolio by lowering its dependence on Humira, its flagship product. AbbVie has one of the most popular cancer drugs in its portfolio, Imbruvica and its newest immunology drugs Skyrizi...

See More

Key Turning Points

3rd Resistance Point 147.50
2nd Resistance Point 146.91
1st Resistance Point 145.97
Last Price 145.02
1st Support Level 144.44
2nd Support Level 143.85
3rd Support Level 142.91

See More

52-Week High 175.91
Fibonacci 61.8% 159.93
Fibonacci 50% 155.00
Fibonacci 38.2% 150.07
Last Price 145.02
52-Week Low 134.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar